Planner
GLP-1 titration planner
A visual escalation timeline of label-aware semaglutide and tirzepatide examples from a start date you choose. Add your vial to see the syringe fill for each step. Concentration math only — it does not replace formulation-specific handling instructions.
- 1
Weeks 1-4 · Sep 23, 2026You are here
0.25 mg
- 2
Weeks 5-8 · Oct 21, 2026
0.5 mg
- 3
Weeks 9-12 · Nov 18, 2026
1 mg
- 4
Weeks 13-16 · Dec 16, 2026
1.7 mg
- 5
Week 17+ · Jan 13, 2027
2.4 mg
Labeled maintenance dose; 1.7 mg is listed as an alternative.
Add your vial amount and reconstitution volume above to see the syringe fill for each step.
Tools
Related tools and references
What this timeline is
An example structure taken from the approved product label — it is not a recommendation, and your prescriber's instructions and the label itself always control. Step increases on these labels are conditional on clinical need and on having spent at least the stated time on the current step, not automatic. The syringe-fill numbers are concentration arithmetic only: draw volume = dose ÷ concentration, and U-100 units = draw volume × 100.
Source: Wegovy label (DailyMed, Novo Nordisk)